Edition:
United Kingdom

Applied Genetic Technologies Corp (AGTC.OQ)

AGTC.OQ on NASDAQ Stock Exchange Global Market

4.40USD
20 Sep 2018
Change (% chg)

$0.05 (+1.15%)
Prev Close
$4.35
Open
$4.35
Day's High
$4.43
Day's Low
$4.30
Volume
7,748
Avg. Vol
13,961
52-wk High
$5.75
52-wk Low
$3.28

Chart for

About

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis (XLRS), over two forms of... (more)

Overall

Beta: 1.61
Market Cap(Mil.): $72.35
Shares Outstanding(Mil.): 18.09
Dividend: --
Yield (%): --

Financials

  AGTC.OQ Industry Sector
P/E (TTM): 241.25 85.68 32.76
EPS (TTM): 0.02 -- --
ROI: 0.33 1.78 14.61
ROE: 0.36 3.27 16.33

BRIEF-Applied Genetic Technologies Qtrly Rev Fell To $3.6 Mln

* Q3 EARNINGS PER SHARE VIEW $-0.41 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

08 May 2018

BRIEF-AGTC Doses First Patient In Phase 1/2 Clinical Study Of Gene Therapy For Treatment Of X-Linked Retinitis Pigmentosa

* AGTC DOSES FIRST PATIENT IN PHASE 1/2 CLINICAL STUDY OF GENE THERAPY FOR TREATMENT OF X-LINKED RETINITIS PIGMENTOSA Source text for Eikon: Further company coverage:

18 Apr 2018

Earnings vs. Estimates